| Literature DB >> 32050363 |
Rajat Nag1, Paul Whyte2, Bryan K Markey3, Vincent O'Flaherty4, Declan Bolton5, Owen Fenton6, Karl G Richards7, Enda Cummins8.
Abstract
Anaerobic digestion (AD) has been identified as one of the cleanest producers of green energy. AD typically uses organic materials as feedstock and, through a series of biological processes, produces methane. Farmyard manure and slurry (FYM&S) are important AD feedstock and are typically mixed with agricultural waste, grass and/or food wastes. The feedstock may contain many different pathogens which can survive the AD process and hence also possibly be present in the final digestate. In this study, a semi-quantitative screening tool was developed to rank pathogens of potential health concern emerging from AD digestate. A scoring system was used to categorise likely inactivation during AD, hazard pathways and finally, severity as determined from reported human mortality rates, number of global human-deaths and infections per 100,000 populations. Five different conditions including mesophilic and thermophilic AD and three different pasteurisation conditions were assessed in terms of specific pathogen inactivation. In addition, a number of scenarios were assessed to consider foodborne incidence data from Ireland and Europe and to investigate the impact of raw FYM&S application (without AD and pasteurisation). A sensitivity analysis revealed that the score for the mortality rate (S3) was the most sensitive parameter (rank coefficient 0.49) to influence the final score S; followed by thermal inactivation score (S1, 0.25) and potential contamination pathways (S2, 0.16). Across all the scenarios considered, the screening tool prioritised Cryptosporidium parvum, Salmonella spp., norovirus, Streptococcus pyogenes, enteropathogenic E. coli (EPEC), Mycobacterium spp., Salmonella typhi (followed by S. paratyphi), Clostridium spp., Listeria monocytogenes and Campylobacter coli as the highest-ranking pathogens of human health concern resulting from AD digestate in Ireland. This tool prioritises potentially harmful pathogens which can emerge from AD digestate and highlights where regulation and intervention may be required.Entities:
Keywords: Anaerobic digestion; Hazard identification; Pasteurisation; Risk assessment; Semi-quantitative screening
Mesh:
Substances:
Year: 2019 PMID: 32050363 PMCID: PMC7126561 DOI: 10.1016/j.scitotenv.2019.136297
Source DB: PubMed Journal: Sci Total Environ ISSN: 0048-9697 Impact factor: 7.963
Fig. 1Observed human disease outbreaks in Europe (last 20 years).
Fig. 2Flow diagram of the screening method.
Time-temperature conditions studied.
| Number | Name | Description | Time | Temperature |
|---|---|---|---|---|
| 1 | M-AD | Mesophilic AD | 4 days | 37 °C |
| 2 | T-AD | Thermophilic AD | 4 days | 55 °C |
| 3 | Pas 1 | Irish pasteurisation | 4 days | 60 °C |
| 4 | Pas 2 | EU pasteurisation | 60 min | 70 °C |
| 5 | Pas 3 | Higher pasteurisation | 60 min | 90 °C |
List of commonly used indicator pathogens.
| Name | Indicator for | Reference |
|---|---|---|
| Escherichia coli | Gram −ve, non-spore forming coliform bacteria | ( |
| Salmonella senftenberg | Gram −ve, non-spore forming bacteria | ( |
| Enterococcus faecalis | Gram + ve, non-spore forming bacteria | ( |
| Clostridium spp. | Gram +ve, spore-forming bacteria | ( |
| Mycobacterium spp. | Acid-fast thermoresistant bacteria | ( |
| Feline calicivirus (FCV) | Virus. Non-envelope virus; more heat resistant. Enteric virus (gene levels of noroviruses) | ( |
| Cryptosporidium parvum | Parasites | ( |
Animal diseases found in Ireland and typical symptoms.
| Diseases | Pathogens | Relative frequency of population deaths (%) in 2016 |
|---|---|---|
| Cattle | ||
| Gastrointestinal infection (Enteritis and Parasitic) | Bovine Diarrhoeal Virus, | 12 |
| Respiratory infections (pneumonia, pleuropneumonia and parasitic bronchitis) | Mycobacterium, Bovine respiratory syncytial virus (RSV), Trueperella pyogenes, Mannheimia haemolytica, Dictyocaulus spp., Mycoplasma bovis, Pasteurella multocida, bovine herpesvirus, Histophilus somni | 17 |
| Systemic infection | Escherichia coli | 5 |
| Clostridial infection | Clostridium novyi, Cl. Chauvoei, Cl. Sordellii, Cl. perfringens, Cl. septicum, Cl. perfringens, Cl. Botulinum | 4 |
| Cardiac infection | Trueperella pyogenes | 9.5 |
| Liver disease | Listeria monocytogenes, Liver fluke | 3.5 |
| Bovine abortion | Trueperella pyogenes, Salmonella Dublin, Bacillus licheniformis, Listeria moncytogenes, Aspergillus spp. | 7.1, 4.8, 4.1, 2.9, 0.6 |
| Bovine mastitis | E. coli, Staphylococcus aureus, Streptococcus uberis | 8, 26.8, 12 |
| Sheep | ||
| Parasitic disease | Teladorsagia (Ostertagia) circumcincta, Haemonchus contortus, Trichostrongylus spp., Nematodirus battus | 13 |
| Respiratory infections | Mannheimia haemolytica, Less commonly (Pasteurella multocida, Trueperella pyogenes, Bibersteinia trehalosi and Mycoplasma ovipneumonae) | 12 |
| Septicaemia | Bibersteinia trehalosi | 15 |
| Clostridial and Kidney disease | Clostridium perfringens, Clostridium difficile | 7 |
| Enteric disease | rotavirus and coronavirus | 7 |
| Ovine abortion | Toxoplasma gondii, Chlamydophila abortus, E. coli, Salmonella Dublin, Trueperella pyogenes, Listeria spp., Streptococcus spp. | 40.2, 26.1, 16.5, 0.8, 4.4, 4.0, 2.0 |
| Pig | ||
| Pneumonia | Pasteurella multocida, Mycoplasma hyopneumoniae, Actinobacillus pleuropeumoniae, Trueperella pyogenes, Swine influenza virus | 29 |
| Colibacillosis and Enteric infection | E. coli, Salmonella, Clostridium perfringens, Clostridium difficile | 22 |
| Septicaemia | Klebsiella pneumoniae, Streptococcus suis, Listeria monocytogenes, E. coli | 12 |
| Nervous disease | Streptococcus suis | 5 |
| Poultry | ||
| Septicaemia | Escherichia coli, Erysipelothrix rhusiopathiae | 26 |
| Digestive | Erysipelothrix rhusiopathiae, Brachyspira spp., adenovirus | 6.5 |
| Musculoskeletal | NA | 8 |
| Respiratory | Adenovirus | 9 |
| Parasitic disease | Dermanyssus gallinae | 15 |
Fig. 3Adopted strategy for S3 scoring.
Scenarios considered.
| Number | Name | Description | Difference from BM | Final score S |
|---|---|---|---|---|
| 1 | Scenario A FOODIRE | Model considering only foodborne illness in Ireland | S3 based on foodborne illness in Ireland (S3IRE) | S1 × S2 × S3IRE |
| 2 | Scenario B FOODEU | Model considering only foodborne illness in the Europe | S3 based on foodborne illness in the Europe (S3EU) | S1 × S2 × S3EU |
| 3 | Scenario C RAWFYM&S | Model considering raw FYM&S application without heat treatment and AD | No S1, only S2 and S3 | S2 × S3 |
Note: The final score S for baseline model (BM) was calculated as S1 × S2 × S3 (Eq. (3)).
Pathogens considered for Scenario A FOODIRE.
| Number | Pathogens | Number of confirmed human cases in Irelandb | Total number of confirmed cases/100,000 population (notification rates)b,d | Avg. value | Score S3IREa | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||
| 1 | 2511 | 2453 | 2593 | 2288 | 2391 | 2433 | 1660 | 1810 | 1752 | 1885 | 53.1 | 53 | 56.3 | 49.8 | 52.17 | 54.3 | 37.15 | 40.67 | 39.8 | 43.7 | 47.999 | 0.9 | |
| 2 | 299 | 270 | 259 | 326 | 309 | 311 | 349 | 335 | 447 | 440 | 6.3 | 5.8 | 5.6 | 7.1 | 6.7 | 6.9 | 7.8 | 7.5 | 10.2 | 10.2 | 7.41 | 0.8 | |
| 3 | 3 | 13 | 5 | 4 | 2 | 6 | 3 | 3 | 3 | 6 | 0.06 | 0.28 | 0.11 | 0.09 | 0.04 | 0.13 | 0.07 | 0.07 | 0.1 | 0.1 | 0.105 | 0.7 | |
| 4 | 737 | 598 | 572 | 564 | 412 | 275 | 197 | 237 | 213 | 115 | 15.6 | 12.92 | 12.42 | 12.29 | 8.99 | 6.14 | 4.41 | 5.33 | 4.8 | 2.7 | 8.56 | 0.8 | |
| 5 | 13 | 19 | 15 | 8 | 11 | 7 | 10 | 10 | 13 | 21 | 0.28 | 0.41 | 0.33 | 0.17 | 0.24 | 0.16 | 0.22 | 0.22 | 0.3 | 0.5 | 0.283 | 0.7 | |
| 6 | 6 | 4 | 0 | 0 | 5 | 9 | 17 | 0.13 | 0.09 | 0 | 0 | 0.11 | 0.2 | 0.4 | 0.132 | 0.7 | |||||||
| 7 | 2 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 2 | 0 | 0.04 | 0 | 0 | 0.02 | 0.02 | 0 | 0.02 | 0.02 | 0 | 0 | 0.012 | 0.6 | |
| 8 | 2 | 0 | 3 | 1 | 2 | 1 | 1 | 0 | 2 | 7 | 0.04 | 0 | 0.07 | 0.02 | 0.04 | 0.02 | 0.02 | 0 | <0.1 | 0.2 | 0.045 | 0.6 | |
| 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | <0.1 | 0.09 | 0.6 | |
| 10 | 3 | 5 | 3 | 6 | 4 | 6 | 7 | 11 | 5 | 5 | 0.06 | 0.11 | 0.07 | 0.13 | 0.08 | 0.13 | 0.16 | 0.25 | 0.11 | <0.1 | 0.122 | 0.7 | |
| 11 | 0 | 1 | 0 | 1 | 1 | 1 | 37 | 0 | 1.5 | 0 | 1.5 | 1.4 | 1.36 | 0.83 | 0.941 | 0.7 | |||||||
| 12 | 0.001 | 0.5 | |||||||||||||||||||||
| 13 | 0.001 | 0.5 | |||||||||||||||||||||
| 14 | Norovirus | 50 | 28 | 1.1 | 0.616 | 0.858 | 0.7 | ||||||||||||||||
| 15 | 0.001 | 0.5 | |||||||||||||||||||||
| 16 | 439 | 394 | 514 | 556 | 428 | 294 | 445 | 416 | 609 | 10.38 | 9.31 | 12.15 | 13.14 | 10.12 | 6.95 | 10.52 | 9.83 | 14.4 | 10.755 | 0.9 | |||
a Scale for selecting score S3IRE based on the total number of confirmed cases/100,000 population (notification rates).
b Blank cells represent unavailability of data in the report.
c Only Cryptosporidium data has been collected from The Health Protection Surveillance Centre (HPSC) (2018).
d
Pathogens considered for Scenario B FOODEU.
| Number | Pathogens | Number of confirmed human cases in the EUb,c | Total number of confirmed cases/100,000 population (notification rates)b,c,d | Avg. value | Score S3EUa | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||
| 1 | 246,307 | 232,134 | 236,818 | 214,710 | 214,300 | 220,209 | 215,397 | 198,725 | 190,579 | 200,980 | 66.3 | 62.9 | 66.5 | 61.4 | 61.7 | 50.28 | 48.56 | 45.57 | 40.7 | 45.2 | 54.911 | 0.9 | |
| 2 | 94,530 | 94,597 | 92,012 | 87,753 | 94,278 | 95,548 | 101,037 | 110,181 | 134,580 | 153,852 | 20.4 | 20.9 | 20.7 | 20.3 | 21.9 | 20.7 | 21.5 | 24 | 26.4 | 31.1 | 22.79 | 0.9 | |
| 3 | 6861 | 6928 | 6435 | 6352 | 6215 | 7017 | 6780 | 7578 | 8356 | 8803 | 1.82 | 1.91 | 1.83 | 1.92 | 1.93 | 1.63 | 1.58 | 1.65 | 1.8 | 2.8 | 1.887 | 0.8 | |
| 4 | 6378 | 5929 | 5900 | 6042 | 5680 | 9485 | 3656 | 3583 | 3159 | 3271 | 1.82 | 1.68 | 1.75 | 1.8 | 1.7 | 1.93 | 0.83 | 0.75 | 0.7 | 0.6 | 1.356 | 0.8 | |
| 5 | 2536 | 2206 | 2242 | 1883 | 1720 | 1476 | 1601 | 1654 | 1425 | 1581 | 0.47 | 0.43 | 0.46 | 0.39 | 0.36 | 0.32 | 0.35 | 0.36 | 0.3 | 0.3 | 0.374 | 0.7 | |
| 6 | 1057 | 822 | 780 | 647 | 518 | 1414 | 1988 | 1660 | 605 | 0.16 | 0.18 | 0.18 | 0.15 | 0.12 | 0.36 | 0.51 | 0.5 | 0.27 | 0.7 | ||||
| 7 | 772 | 883 | 820 | 805 | 865 | 781 | 756 | 775 | 909 | 972 | 0.2 | 0.2 | 0.19 | 0.18 | 0.2 | 0.18 | 0.16 | 0.18 | 0.2 | 0.2 | 0.189 | 0.7 | |
| 8 | 516 | 437 | 462 | 498 | 503 | 330 | 356 | 404 | 735 | 639 | 0.12 | 0.09 | 0.09 | 0.1 | 0.1 | 0.07 | 0.07 | 0.08 | 0.1 | 0.1 | 0.092 | 0.6 | |
| 9 | 101 | 156 | 324 | 217 | 301 | 268 | 223 | 750 | 670 | 787 | 0.02 | 0.03 | 0.06 | 0.04 | 0.06 | 0.05 | 0.05 | 0.16 | 0.1 | 0.2 | 0.077 | 0.6 | |
| 10 | 170 | 181 | 167 | 144 | 132 | 132 | 165 | 134 | 123 | 113 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | <0.1 | 0.031 | 0.6 | |
| 11 | 47 | 288 | 258 | 213 | 144 | 21 | 289 | 11 | 16 | 1.57 | 8.27 | 7.4 | 6.2 | 4.2 | 0.56 | 0.65 | 4.121 | 0.8 | |||||
| 12 | 76 | 29 | 17 | <0.01 | <0.01 | 0.009 | 0.5 | ||||||||||||||||
| 13 | 49 | 60 | 1727 | 2009 | 1729 | 1050 | 795 | 1704 | 857 | 0.01 | 0.01 | 0.04 | 0.06 | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 | 0.028 | 0.6 | |||
| 14 | Norovirus | 11,993 | 13,536 | 3580 | 2023 | 13,987 | 2529 | 6533 | 2670 | 3617 | 0.08 | 0.06 | 0.23 | 0.123 | 0.7 | ||||||||
| 15 | 155 | 78 | 48 | 1444 | 116 | 7 | 13 | 2 | 104 | <0.01 | <0.01 | <0.01 | 0.009 | 0.5 | |||||||||
| 16 | 62 | 120 | 24 | 65 | 11 | 20,000 | 12,700 | 87 | <0.01 | <0.01 | <0.01 | 0.009 | 0.5 | ||||||||||
a Scale for selecting score S3EU based on the total number of confirmed cases/100,000 population (notification rates).
b Iceland, Norway, Switzerland are excluded; no special agreement for data.
c Blank cells represent unavailability of data in the report.
d
Fig. 4The result of the screening model with five different conditions (BM).
Fig. 5Ranking of top 14 pathogens based on qualitative screening process (BM).
Fig. 6Bin distribution of the final score (S).
List of top scored pathogens from screening method and comparison with the indicator pathogens (baseline model BM).
| Number | Name | Type | Indicator |
|---|---|---|---|
| 1 | Cryptosporidium parvum | Parasites: Protozoa | Itself |
| 2 | Streptococcus pyogenes | Gram +ve, aerobe, non-spore forming, non-coliform bacteria | Clostridium |
| 3 | Entamoeba histolytica | Parasites: Protozoa | Cryptosporidium |
| 4 | Salmonella enterica spp. | Gram −ve, facultative anaerobe, non-spore forming, coliform bacteria | Itself Salmonella senftenberg (more heat resistant) |
| 5 | Ascaris spp. | Parasites: helminths | Cryptosporidium |
| 6 | E. coli enteropathogenic (EPEC) | Gram −ve, facultative anaerobe, non-spore forming coliform bacteria | Itself |
| 7 | Mycobacterium spp. | Acid-fast thermoresistant bacteria | Itself |
| 8 | Salmonella typhi followed by S. paratyphi | Gram −ve, facultative anaerobe, non-spore forming, coliform bacteria | Itself Salmonella senftenberg (more heat resistant) |
| 9 | Giardia lamblia, Giardia intestinalis | Parasites: Protozoa | Cryptosporidium |
| 10 | Shigella spp. | Gram −ve, facultative anaerobe, non-spore forming, coliform bacteria | E. coli, Salmonella senftenberg |
| 11 | Norovirus (surrogated by FCV) | Virus | Itself |
| 12 | Enterobacter spp. | Gram −ve, facultative anaerobe, non-spore forming coliform bacteria | E. coli, Salmonella senftenberg |
| 13 | Clostridium spp. | Gram +ve, spore-forming bacteria | Itself |
| 14 | Listeria monocytogenes | Gram +ve, facultative anaerobe, non-spore forming, non-coliform bacteria | Itself/Enterococcus faecalis |
Fig. 7Ranking of top pathogens in different scenarios.
Fig. 8The correlation coefficient (Spearman rank) of three different scores S1, S2 and S3 for the top 14 pathogens (BM).
List of pathogens (other than which are mentioned in Table S1) potentially representing an animal hazard (animal only, not human) and comparison with the indicators (AFBI and DAFM, 2016).
| Number | Pathogen name/cause | Name of hazard | Classification | Affected animals | Indicator | |||
|---|---|---|---|---|---|---|---|---|
| Cattle | Sheep | Pig | Poultry | |||||
| 1 | Actinobacillus pleuropneumoniae | Porcine pleuropneumonia | Gram-negative, facultative anaerobic bacteria | ✓ | Escherichia coli/Salmonella enterica spp. | |||
| 2 | African Swine Fever virus (ASFV) | African Swine Fever (ASF) | Virus | Feline calicivirus (FCV) | ||||
| 3 | Babesia spp. | Babesiosis/tick-borne disease | protozoan parasite | ✓ | Cryptosporidium parvum | |||
| 4 | Bibersteinia trehalosi | Pneumonia | Gram-negative, facultative anaerobic bacteria | ✓ | ✓ | Escherichia coli/Salmonella enterica spp. | ||
| 5 | Bluetongue virus | Bluetongue Disease (BT) | Virus | Feline calicivirus (FCV) | ||||
| 6 | Bordetella bronchiseptica | Infectious bronchitis | Gram-negative, rod-shaped bacteria | ✓ | Escherichia coli/Salmonella enterica spp. | |||
| 7 | Bovine Respiratory Syncytial virus | Respiratory disease | Virus | ✓ | Feline calicivirus (FCV) | |||
| 8 | Brachyspira spp. | diarrheal disease | Gram-negative, anaerobic bacteria | ✓ | Escherichia coli/Salmonella enterica spp. | |||
| 9 | Chlamydophila abortus | Abortion and fetal death in mammals | Gram-negative bacteria | ✓ | Escherichia coli/Salmonella enterica spp. | |||
| 10 | Circovirus 2 | Affecting liver, lung etc. | Virus | ✓ | Feline calicivirus (FCV) | |||
| 11 | Coccidian protozoa | Parasitic/Coccidiosis | Protozoa | ✓ | Cryptosporidium parvum | |||
| 12 | Dermanyssus gallinae | Affecting production and hen health | Parasites: Red mite, Arthropoda | ✓ | Cryptosporidium parvum | |||
| 13 | Dictyocaulus viviparus | Parasitic pneumonia | Parasites: helminths | ✓ | Ascaris/Cryptosporidium parvum | |||
| 14 | Echinostomida spp. | Paramphistomosis | Parasites: helminths | ✓ | Ascaris/Cryptosporidium parvum | |||
| 15 | Eimeria spp. | Coccidiosis | protozoan parasites | ✓ | ✓ | Cryptosporidium parvum | ||
| 16 | Erysipelothrix rhusiopathiae | Erysipelas | Gram-positive, facultative anaerobic bacteria | ✓ | Enterococcus faecalis | |||
| 17 | Chronic fasciolosis | Parasites: helminths | ✓ | Ascaris/Cryptosporidium parvum | ||||
| 18 | Herpesvirus | Neoplasia/Marek's disease | Virus | ✓ | ✓ | Feline calicivirus (FCV) | ||
| 19 | Histophilus somni | Bovine respiratory disease | Gram-negative, facultative anaerobic bacteria | ✓ | Escherichia coli/Salmonella enterica spp. | |||
| 20 | Mannheimia haemolytica | Respiratory disease | Gram-negative, anaerobic bacteria | ✓ | ✓ | Escherichia coli/Salmonella enterica spp. | ||
| 21 | Mycoplasma spp. | Pneumonia | Gram-positive bacteria | ✓ | ✓ | ✓ | Clostridium/Enterococcus faecalis | |
| 22 | Nematode (Roundworms) | Parasitic gastroenteritis | Parasites: helminths | ✓ | Ascaris/Cryptosporidium parvum | |||
| 23 | Newcastle Disease virus | Newcastle Disease | Virus | Feline calicivirus (FCV) | ||||
| 24 | Pasteurella spp. | Septicaemia | Gram-negative, facultative anaerobic bacteria | ✓ | ✓ | ✓ | Escherichia coli/Salmonella enterica spp. | |
| 25 | Retrovirus | Enzootic Bovine Leukosis (EBL) | Virus | Feline calicivirus (FCV) | ||||
| 26 | Rumen fluke | Liver fluke disease | Parasites: helminths | ✓ | ✓ | Ascaris/Cryptosporidium parvum | ||
| 27 | Trueperella pyogenes | Abscesses, mastitis, metritis, and pneumonia | Gram-positive, facultative anaerobic bacteria | ✓ | ✓ | ✓ | Enterococcus faecalis | |
The health status of animals on the island of Ireland benefits from our island status and the geographical buffer provided by Great Britain and Western Europe.
Zoonotic.
Likely levels and sources of parasites can be found in urban wastewater and hospital waste.
| Pathogen name | Likely levels | Unit | Source | Reference |
|---|---|---|---|---|
| Ascaris | 0.7 to 13.33 | eggs l−1 | Wastewater | ( |
| 10.08 to 24.36 | Urban raw wastewater | ( | ||
| 1344 to 4116 | Animal wastewater | |||
| Ancylostoma duodenale | 100–150 | eggs g−1 | Affected human stool | ( |
| Mean intensity of infection was 250.1 ± 64.4 | Affected human stool | ( | ||
| Toxocara spp. | 0–4.35 | eggs g−1 | Sand sample contaminated with faeces | ( |
| mean 4.24 ± 4.62 and median 2.17 ± 5.92 | Hair sample of contaminated dogs | ( | ||
| Trichinella spp. | 2 to 295 | larvae g−1 | Contaminated meat | ( |
| Entamoeba histolytica | 2.5 × 10^2 to 5.0 × 10^2 | cysts l−1 | Wastewater treatment plant influent | ( |
| 39–308 | cysts g−1 | Faecal sample collected from infected patients in hospitals | ( | |
| Echinococcus multilocularis | 20–140 | eggs g−1 | Faecal sample of infected dog; mostly red fox and racoon dogs; very rare disease in Europe | ( |
| Echinococcus granulosus |
Final comparison checklist and selection of top-ranked pathogens.
Note: Highlighted pathogens are present in municipal wastewater only (Table 9) and therefore not considered.